Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells

Overview

Journal Front Pharmacol

Date 2018 Jun 13

PMID 29892225

Citations 5

Authors

Xi Dai

Run-Ze Li

Ze-Bo Jiang

Chun-Li Wei

Lian-Xiang Luo

Xiao-Jun Yao

Guo-Ping Li

Elaine L-H Leung

Affiliations

Soon will be listed here.

Abstract

Honokiol is a natural compound with small molecular structure and extracted from bark of magnolia trees. The biological activities of honokiol include anti-oxidation, anti-inflammation as well as anti-tumor. However, their mechanism remains unknown. In this study, A549 cell line and EGFR-mutant cell line PC-9 with higher expression level of Lyn than A549 cells were used to assess the anti-tumor effects of honokiol. As shown in this study, honokiol is an effective drug on inhibiting proliferation and inducing apoptosis depended on Lyn and EGFR signal pathway regulated by Lyn, and its efficacy is stronger in PC-9 cells than A549 cells. In addition, this anti-tumor effect in PC-9 cells was weakened by Lyn-knockdown. Taken together, this study indicated the mechanism of honokiol on lung adenocarcinoma and provides a possibility of honokiol as an effective anti-tumor medicine.

Citing Articles

Role of sex in immune response and epigenetic mechanisms.

Bhattacharya S, Sadhukhan D, Saraswathy R Epigenetics Chromatin. 2024; 17(1):1.

PMID: 38247002 PMC: 10802034. DOI: 10.1186/s13072-024-00525-x.

Magnolol and Honokiol Inhibited the Function and Expression of BCRP with Mechanism Exploration.

Yu C, Li P, Chen S, Lin S, Hou Y Molecules. 2021; 26(23).

PMID: 34885972 PMC: 8659015. DOI: 10.3390/molecules26237390.

Honokiol: A Review of Its Anticancer Potential and Mechanisms.

Ong C, Lee W, Tang Y, Yap W Cancers (Basel). 2019; 12(1).

PMID: 31877856 PMC: 7016989. DOI: 10.3390/cancers12010048.

Progress in Research on the Role of Flavonoids in Lung Cancer.

Zanoaga O, Braicu C, Jurj A, Rusu A, Buiga R, Berindan-Neagoe I Int J Mol Sci. 2019; 20(17).

PMID: 31480720 PMC: 6747533. DOI: 10.3390/ijms20174291.

Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway.

Lee J, Sul J, Park J, Lee M, Cha E, Ko Y Int J Mol Med. 2019; 43(5):1969-1978.

PMID: 30864681 PMC: 6443331. DOI: 10.3892/ijmm.2019.4122.

References

Luo L, Li Y, Liu Z, Fan X, Duan F, Li R . Honokiol Induces Apoptosis, G1 Arrest, and Autophagy in KRAS Mutant Lung Cancer Cells. Front Pharmacol. 2017; 8:199. PMC: 5387050. DOI: 10.3389/fphar.2017.00199. View

Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell P, Govindarajan B . Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem. 2003; 278(37):35501-7. DOI: 10.1074/jbc.M302967200. View

Jiang Q, Fan L, Yang G, Guo W, Hou W, Chen L . Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model. BMC Cancer. 2008; 8:242. PMC: 2543046. DOI: 10.1186/1471-2407-8-242. View

Wu S, Shih J . Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer. Mol Cancer. 2018; 17(1):38. PMC: 5817870. DOI: 10.1186/s12943-018-0777-1. View

Shigemura K, Arbiser J, Sun S, Zayzafoon M, Johnstone P, Fujisawa M . Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer. 2007; 109(7):1279-89. DOI: 10.1002/cncr.22551. View

Huang T, Huo L, Wang Y, Xia W, Wei Y, Chang S . Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers. Cancer Cell. 2013; 23(6):796-810. PMC: 3703149. DOI: 10.1016/j.ccr.2013.04.027. View

Wang T, Chen F, Chen Z, Wu Y, Xu X, Zheng S . Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol. 2004; 10(15):2205-8. PMC: 4724979. DOI: 10.3748/wjg.v10.i15.2205. View

Westover D, Zugazagoitia J, Cho B, Lovly C, Paz-Ares L . Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors. Ann Oncol. 2018; 29(suppl_1):i10-i19. PMC: 6454547. DOI: 10.1093/annonc/mdx703. View

Battle T, Arbiser J, Frank D . The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood. 2005; 106(2):690-7. DOI: 10.1182/blood-2004-11-4273. View

10.

Li L, Han W, Gu Y, Qiu S, Lu Q, Jin J . Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res. 2007; 67(10):4894-903. DOI: 10.1158/0008-5472.CAN-06-3818. View

11.

Iida M, Brand T, Campbell D, Li C, Wheeler D . Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor. Oncogene. 2012; 32(6):759-67. PMC: 3381861. DOI: 10.1038/onc.2012.90. View

12.

Park E, Min H, Chung H, Hong J, Kang Y, Manh Hung T . Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Lett. 2009; 277(2):133-40. DOI: 10.1016/j.canlet.2008.11.029. View

13.

Ahn K, Sethi G, Shishodia S, Sung B, Arbiser J, Aggarwal B . Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res. 2006; 4(9):621-33. DOI: 10.1158/1541-7786.MCR-06-0076. View

14.

Wolf I, OKelly J, Wakimoto N, Nguyen A, Amblard F, Karlan B . Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol. 2007; 30(6):1529-37. View

15.

Leeman-Neill R, Cai Q, Joyce S, Thomas S, Bhola N, Neill D . Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin Cancer Res. 2010; 16(9):2571-9. PMC: 2871379. DOI: 10.1158/1078-0432.CCR-10-0333. View

16.

Siegel R, Naishadham D, Jemal A . Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1):11-30. DOI: 10.3322/caac.21166. View

17.

Song J, Anandharaj A, Upadhyaya P, Kirtane A, Kim J, Hong K . Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget. 2016; 7(36):57752-57769. PMC: 5295387. DOI: 10.18632/oncotarget.10759. View

18.

Liu J, Wang S, Zhang Y, Fan H, Lin H . Traditional Chinese medicine and cancer: History, present situation, and development. Thorac Cancer. 2015; 6(5):561-9. PMC: 4567000. DOI: 10.1111/1759-7714.12270. View

19.

Sutton P, Borgia J, Bonomi P, Plate J . Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells. Mol Cancer. 2013; 12:76. PMC: 3725175. DOI: 10.1186/1476-4598-12-76. View

20.

Lee D, Szczepanski M, Lee Y . Magnolol induces apoptosis via inhibiting the EGFR/PI3K/Akt signaling pathway in human prostate cancer cells. J Cell Biochem. 2009; 106(6):1113-22. DOI: 10.1002/jcb.22098. View